Streetbeat News

Revenues

LMAT

LeMaitre Vascular forecasts Q1 EPS of $0.36-$0.41, surpassing the $0.34 estimate, with sales expected between $50.5M-$52.9M, also above the $50.21M estimate. For FY24, the company anticipates an EPS of $1.60-$1.71, exceeding the $1.53 estimate, and sales projections of $209.7M-$214.3M, slightly above the $209.99M estimate.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:39 pm

MASI

Masimo Corporation projects its FY24 adjusted EPS to be between $3.44 and $3.60, surpassing the estimated $3.32. The company also forecasts revenue to range from $2.045 billion to $2.165 billion, which brackets the $2.103 billion estimate.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:37 pm

ARRY

Array Technologies forecasts its FY24 revenue to be between $1.25B and $1.4B, which is below the estimated $1.86B. Additionally, its adjusted EPS is expected to be between $1.00 and $1.15, also lower than the estimated $1.27.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:36 pm

SSTI

SoundThinking (SSTI) has provided revenue guidance for FY24, projecting revenues to be between $104M and $106M, with an estimated midpoint of $105.388M. Additionally, the company anticipates Adjusted EBITDA margins to range from 18% to 20% for the full year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:35 pm

ASTH

Astrana Health projects its FY24 earnings per share (EPS) to be between $1.28 and $1.52, with revenue forecasts ranging from $1.650 billion to $1.850 billion.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:32 pm

PGNY

Progyny forecasts Q1 revenue to be between $285M-$292M, below the estimated $312.64M, but expects adjusted EPS of $0.33-$0.35, above the estimated $0.18.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:31 pm

ASTH

Astrana Health reported a Q4 2023 EPS of $0.26, a significant increase from the previous year's $(0.08). Revenue for the quarter was $353M, up from $294.2M YoY.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:30 pm

PGNY

Progyny forecasts its 2024 revenue to be between $1.285 billion and $1.315 billion, slightly surpassing the estimated $1.311 billion. The company also anticipates its adjusted EPS to range from $1.54 to $1.59, significantly higher than the estimated $0.70.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:30 pm

TMCI

Treace Medical Concepts Inc. (TMCI) forecasts its FY24 revenue to be in the range of $220M-$225M, which is around the analyst estimate of $223.16M.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:26 pm

RDNT

RadNet is set to acquire assets from Houston Medical Imaging, including seven centers that will continue operating under the Houston Medical Imaging brand. These centers, offering a range of services such as MRI and CT scans, collectively performed over 135,000 procedures and generated over $28 million in revenue in 2023.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:26 pm